Abound Wealth Management Neogenomics Inc Transaction History
Abound Wealth Management
- $301 Billion
- Q3 2024
A detailed history of Abound Wealth Management transactions in Neogenomics Inc stock. As of the latest transaction made, Abound Wealth Management holds 12 shares of NEO stock, worth $189. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 14
14.29%
Holding current value
$189
Previous $195,000
9.23%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NEO
# of Institutions
276Shares Held
127MCall Options Held
581KPut Options Held
115K-
Black Rock Inc. New York, NY19.7MShares$310 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$223 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$138 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$106 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$104 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.98B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...